The Spectrum of Pulmonary Toxicity in Pancreatic Cancer Patients Receiving Gemcitabine Combination Chemotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
The Spectrum of Pulmonary Toxicity in Pancreatic Cancer Patients Receiving Gemcitabine Combination Chemotherapy ; volume:12 ; number:2 ; year:2019 ; pages:506-512
Case reports in oncology ; 12, Heft 2 (2019), 506-512
- Creator
-
Baig, Jalal
Shokouh-Amiri, Mohammad
Chan, Juliana
Chowdhery, Rozina
Danthurthy, Samaya
Venepalli, Neeta K.
- DOI
-
10.1159/000500242
- URN
-
urn:nbn:de:101:1-2019091200202622585447
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Baig, Jalal
- Shokouh-Amiri, Mohammad
- Chan, Juliana
- Chowdhery, Rozina
- Danthurthy, Samaya
- Venepalli, Neeta K.
Other Objects (12)
Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series
Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy
Impact of liver fibrosis on survival of patients with intrahepatic cholangiocarcinoma receiving gemcitabine-based chemotherapy
Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma
Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy
ASSESSMENT OF NUTRITIONAL STATUS OF PATIENTS RECEIVING CHEMOTHERAPY
Gemcitabine–cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study
Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients
Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series
Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy
Impact of liver fibrosis on survival of patients with intrahepatic cholangiocarcinoma receiving gemcitabine-based chemotherapy
Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma
Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy
ASSESSMENT OF NUTRITIONAL STATUS OF PATIENTS RECEIVING CHEMOTHERAPY
Gemcitabine–cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study
Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients
Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series
Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy
Impact of liver fibrosis on survival of patients with intrahepatic cholangiocarcinoma receiving gemcitabine-based chemotherapy
Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma
Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy
ASSESSMENT OF NUTRITIONAL STATUS OF PATIENTS RECEIVING CHEMOTHERAPY
Gemcitabine–cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study